Part of Catalent, Inc., Columbia Laboratories (Bermuda) Ltd. is a Bermudian company located in Hamilton. The firm manufactures pharmaceutical products.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Engaged in manufacturing, fabricating or processing drugs in pharmaceutical preparations

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Sure Medical, Inc., a subsidiary of Biomed Research Technologies, Inc., is an American company that develops drugs for the improved therapy for respiratory disease, glaucoma, anaphylaxis and other diseases. The firm was acquired by Biomed Research Technologies, Inc. on May 29, 2001.

Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO.

The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and\nother related life-threatening illnesses.

The Jordanian Pharmaceutical Manufacturing Co. engages in the manufacture and distribution of generic medicines, medical appliances, and cosmetics. Its products include tablets, capsules, suppositories, injectable, syrups, and suspensions. It operates through the Inside Jordan and Outside Jordan geographical segments. The company was founded in 1978 and is headquartered in Amman, Jordan.

Aventis Pharmaceuticals is a pharmaceutical company manufacturing drugs for a variety of diseases and disorders. The company is based in India and manufactures drugs for cardiovascular, thrombotic, metabolic disorders, oncology and disorders of the nervous system. The company was the world’s first pharmaceutical company to market an insulin drug for daily use.   The company was founded in 1956 as Hoechst Fedco Pharma. The company is now part of the Sanofi-Aventis group.

Columbia Laboratories as the Pacific Northwest’s latest brand for high quality analytical testing.

Adcock Ingram Ltd. manufactures and markets pharmaceuticals, personal care, and household hygiene products. The firm's products are used in the areas of cardiovascular, central nervous system, dermatology, diabetes, ear, nose and eye preparations, feminine health, and analgesics. The company was founded in 1890 and is headquartered in Bryanston, South Africa.

Draco provides concrete additives, concrete curing, mold oils, plastering, anchoring, installation, decorative concrete-asphalt, floor coverings, thermal insulation, water isolation, primer, adhesives, ceramic adhesives, protective coatings, and so on.

Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others. Its services include custom development and manufacturing services and supply chain management. The company was founded by Il-Han New on June 20, 1926 and is headquartered Seoul, South Korea.

Beijing Yingkerui Innovative Drug Research Co., Ltd., established on 2015-09-23, Business scope includes medical research and experimental development;technology development,transfer,consult,Serve;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Suzhou Hongsen Pharmaceutical Co., Ltd., established on 2009-04-17, Business scope includes production,Sales of sterile raw materials(Cephalosporins),tablet(Contains anti-tumor),hard capsule(Contains anti-tumor),small volume injection(Hormone),Freeze-dried powder injection(Contains anti-tumor),inhalation solution,API(Contains cephalosporins,Contains anti-tumor)and pharmaceutical excipients,intermediate;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Manufacturing of plastic products;Sales of plastic products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Increase Innovative Medicine Holding Co. Ltd. is a Chinese company located in Beijing that engages in drug research and development. The firm was founded in 2005 by Bao Xian Zhang.